feed,title,long_url,short_url
Benzinga,Moderna's Phase 3 COVID-19 Vaccine Shows 95% Efficacy,https://www.benzinga.com/news/20/11/18379862/modernas-phase-3-covid-19-vaccine-shows-95-efficacy,https://j.mp/36JNZXO
Benzinga,Biglari Capital Corp. Issues Statement On Why It Is Urgent To Add An Independent Nominee To Cracker Barrel Board Of Directors,https://www.benzinga.com/pressreleases/20/11/n18379949/biglari-capital-corp-issues-statement-on-why-it-is-urgent-to-add-an-independent-nominee-to-cracker,https://j.mp/36GrItT
Benzinga,Parsons Eclipses $450M in OTA Awards,https://www.benzinga.com/pressreleases/20/11/n18379935/parsons-eclipses-450m-in-ota-awards,https://j.mp/32OAsgK
Benzinga,Harpoon Therapeutics to Participate in the 32nd Annual Piper Sandler Healthcare Conference,https://www.benzinga.com/pressreleases/20/11/g18379917/harpoon-therapeutics-to-participate-in-the-32nd-annual-piper-sandler-healthcare-conference,https://j.mp/36LMuIW
Benzinga,Progenity to Participate in the 32nd Annual Piper Sandler Healthcare Conference,https://www.benzinga.com/pressreleases/20/11/g18379916/progenity-to-participate-in-the-32nd-annual-piper-sandler-healthcare-conference,https://j.mp/3lDqCFD
Benzinga,Spark Therapeutics Expands Visionary Leadership with Appointment of Michael Retterath as Chief Strategy Officer,https://www.benzinga.com/pressreleases/20/11/g18379915/spark-therapeutics-expands-visionary-leadership-with-appointment-of-michael-retterath-as-chief-str,https://j.mp/3nxPQ8P
Benzinga,"Crinetics Pharmaceuticals Appoints Acromegaly Expert, Peter Trainer, Vice President of Clinical Endocrinology",https://www.benzinga.com/pressreleases/20/11/g18379914/crinetics-pharmaceuticals-appoints-acromegaly-expert-peter-trainer-vice-president-of-clinical-endo,https://j.mp/36GZgs4
Benzinga,Nuvei To Participate in Upcoming Investor Conferences,https://www.benzinga.com/pressreleases/20/11/g18379911/nuvei-to-participate-in-upcoming-investor-conferences,https://j.mp/3f42OYX
Benzinga,Otonomy to Participate in Two Upcoming Investor Conferences,https://www.benzinga.com/pressreleases/20/11/g18379909/otonomy-to-participate-in-two-upcoming-investor-conferences,https://j.mp/32OGI8d
